Avalo Therapeutics, Inc.
$927.80M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15725.35x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17479.74x
$19.23Latest market snapshot
Implied fair value · at SVC's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×0.54x SVC P/S=$0.00
Market $19.23Implied $0.00
SVC · current priceP/S 0.54x
$7.61Latest market snapshot
Implied fair value · at AVTX's multiple
$244,946.513,218,645.2% above market
14.01 SVC revenue / share×17479.74x AVTX P/S=$244,946.51
Market $7.61Implied $244,946.51